Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Associated Press/Washington Post examine contributions of military research to reducing global disease burden

In light of the U.S. Army's announcement yesterday that an experimental HIV vaccine trial it is sponsoring in Thailand showed modest potential for preventing infection, the Associated Press/Washington Post examines how military research is contributing to the fight against major diseases around the world.

25 Sep 2009

WHO lowers expectation of H1N1 vaccine output, appeals for donations to fight pandemic

International drug makers are expected to produce three billion doses of the H1N1 (swine flu) vaccine, "enough for just under half the world's population," a WHO official said Thursday, Canwest News Service/Ottawa Citizen reports. "The agency was hoping pharmaceutical companies would be able to make about five billion doses a year, but data collected over the summer led to the revised estimate," the news service writes (Fitzpatrick, 9/24).

25 Sep 2009

Fourth-quarter and fiscal year end 2009 results announced by Noveko International

Noveko International Inc. ("the Company") today announces the financial results for its fourth quarter and fiscal year ended June 30, 2009.

25 Sep 2009

H1N1 influenza pandemic could present a host of medical ethics issues: JCB

The anticipated onset of a second wave of the H1N1 influenza pandemic could present a host of thorny medical ethics issues best considered well in advance, according to the University of Toronto Joint Centre for Bioethics, which today released nine papers for public discussion.

25 Sep 2009

Regence offers coverage to meet the costs associated with H1N1

To remove financial barriers associated with administration of the H1N1 vaccine and to encourage members to seek vaccination, Regence BlueCross BlueShield will provide coverage for the costs associated with the administration of the H1N1 vaccine during the 2009-2010 flu season, waiving co-pays and deductibles for all members covered by its insured plans. Regence will strongly encourage self-insured employers to cover the full cost to ensure that the greatest number of people are protected.

24 Sep 2009

New report on CEL-SCI's H1N1 flu drug candidate

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published a new report about CEL-SCI Corporation's new H1N1 flu drug candidate.

24 Sep 2009

Polycom's scalable solutions for the healthcare industry

Polycom, Inc., the global leader in telepresence, video and voice communication solutions, is making it easier and more cost-effective for hospitals and other healthcare organizations to deploy and scale telehealth and telemedicine networks. Through an enhanced, highly scalable solution, Polycom allows healthcare organizations to easily and securely extend visual communication capabilities outside of their private networks to a broader group of partner hospitals, community clinics and physicians.

24 Sep 2009

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

CEL-SCI Corporation (NYSE AMEX: CVM), a developer of vaccines and therapeutics for the treatment of infectious diseases and a late-stage oncology company, announced today that it has hired a full-service Clinical Research Organization (CRO) with an office in the Washington, D.C./Baltimore area to support its conduct of the upcoming clinical trial of its investigational LEAPS-H1N1 treatment.

24 Sep 2009

Obama addresses U.N. General Assembly, calls for 'new era of engagement'

In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).

24 Sep 2009

It is possible to reduce the risk of HIV infection with a vaccine: AVAC

"Today marks an historic milestone in the search for an AIDS vaccine; we now have evidence that it is possible to reduce the risk of HIV infection with a vaccine," said AVAC executive director Mitchell Warren, reacting to the results of the first AIDS vaccine trial to ever show efficacy at preventing HIV. "It will take time and resources to fully analyze, understand and validate the data, but there is little doubt that this finding will energize and redirect the AIDS vaccine field as all of us begin the hard work to translate this landmark result into true public health benefit."

24 Sep 2009

Pregnant women must be vaccinated against H1N1 and seasonal flu

Pregnant women should be sure to get all their flu shots as soon as the vaccines become available this year to protect them against both the seasonal flu and the H1N1 (swine) flu, according to eight leading national maternal and infant health organizations.

24 Sep 2009

Global effort needed to protect people from species-crossing diseases, Report finds

A team of health experts on Tuesday called for the U.S. "to lead a global effort to protect people from new outbreaks of deadly infectious diseases that originate in animals, such as swine flu, AIDS and SARS," Reuters writes (Morgan, 9/22).

24 Sep 2009

Study of new swine flu vaccines looks for local children to take part

Paediatricians at Bristol Children's Vaccine Centre are looking for 170 children to take part in a study of the two swine 'flu vaccines due to be used in the UK this winter.

23 Sep 2009

Report outlining global weaknesses in preventing deadly diseases

Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.

23 Sep 2009

Automated software solution for H1N1 preparation

San Diego-based Concerro, Inc., the market leader in enterprise-wide hospital shift and emergency workforce management software, is pleased to announce the launch of PanFluAware™, an automated software solution and decision making system for H1N1 preparation and response. A free webcast demonstration will be held on Friday, September 25th at 1:00 PM eastern standard time.

23 Sep 2009

Report on species-crossing microbes and H1N1

23 Sep 2009

Noveko to provide antimicrobial face masks and respirators to Air Transat

Noveko International Inc. ("the Company") announces that its subsidiary Noveko Inc. ("Noveko") has won a first order from Air Transat, Canada's leading holiday travel airline, for some 500,000 Noveko(TM) antimicrobial face masks and respirators as well as for AZURO(TM) hand sanitizers.

23 Sep 2009

Axion Health and CHS to deliver Workforce Emergency Preparedness and Response programs

Axion HealthTM (www.axionhealth.com), a workforce health protection, emergency preparedness and response provider, today announced that it will partner with Comprehensive Health Services, Inc. (www.chsmedical.com), the industry’s largest independent provider of onsite health centers, nationwide exam programs and rapid response medical readiness teams for workforce health to deliver its ReadySetTM Program for Workforce Emergency Preparedness and Response; including the ReadySet Pandemic Program for prevention, protection and response to pandemic health threats.

23 Sep 2009

Academy of Friends announces its 2009-2010 fundraising for 11 Bay Area HIV/AIDS service organizations

Academy of Friends proudly announces its 2009-2010 fundraising for 11 Bay Area HIV/AIDS service organizations. Known for its annual Academy Awards® Night Charity Gala and monthly social events, AOF raised more than $7.5 million benefitting over 70 organizations serving more than 250,000 people over the last 30 years.

23 Sep 2009

Chan calls for additional H1N1 vaccines for poor countries during WHO Asia-Pacific regional meeting

During the WHO Asia-Pacific regional meeting Monday, WHO Director-General Margaret Chan discussed the organization's efforts to ensure that poor nations have access to H1N1 vaccines, VOA News reports (Bayron, 9/21).

23 Sep 2009

Pandemic News and Research

Further Reading

Associated Press/Washington Post examine contributions of military research to reducing global disease burden

WHO lowers expectation of H1N1 vaccine output, appeals for donations to fight pandemic

Fourth-quarter and fiscal year end 2009 results announced by Noveko International

H1N1 influenza pandemic could present a host of medical ethics issues: JCB

Regence offers coverage to meet the costs associated with H1N1

New report on CEL-SCI's H1N1 flu drug candidate

Polycom's scalable solutions for the healthcare industry

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

Obama addresses U.N. General Assembly, calls for 'new era of engagement'

It is possible to reduce the risk of HIV infection with a vaccine: AVAC

Pregnant women must be vaccinated against H1N1 and seasonal flu

Global effort needed to protect people from species-crossing diseases, Report finds

Study of new swine flu vaccines looks for local children to take part

Report outlining global weaknesses in preventing deadly diseases

Automated software solution for H1N1 preparation

Report on species-crossing microbes and H1N1

Noveko to provide antimicrobial face masks and respirators to Air Transat

Axion Health and CHS to deliver Workforce Emergency Preparedness and Response programs

Academy of Friends announces its 2009-2010 fundraising for 11 Bay Area HIV/AIDS service organizations

Chan calls for additional H1N1 vaccines for poor countries during WHO Asia-Pacific regional meeting

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News